sarilumab
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Evidence suggests that effects of interleukin‐6 pathway inhibitors sarilumab, tocilizumab, and sirukumab on absolute neutrophil…
Posoudit ucinnost a bezpecnost sarilumabu, lidske protilatky proti receptoru interleukinu-6, pro lecbu neinfekcni uveitidy…
Purpose Treatment outcomes and direct medical costs were examined, from a US health payer perspective, of monotherapy with…
Background Two studies (PDY14191 [NCT02404558]: randomised, open-label, Japanese patients; 6R88-RA-1309 [NCT02097524]: randomised…
Background: In rheumatoid arthritis (RA), the efficacy and safety of Certolizumab pegol (CZP) is well stablished, as reported in…
Background A therapeutic revolution in the past decade is still a considerable unmet need in the treatment of rheumatoid…
Background The investigational drug sarilumab is a human monoclonal antibody directed against the interleukin 6 receptor.1 The…
Background Sarilumab, an investigational human IL-6 receptor mAb, demonstrated statistically significant improvements in signs…
Background The investigational agent sarilumab is a human monoclonal antibody directed against the interleukin 6 (IL-6) receptor…
IL6 is a pro-inflammatory cytokine that is expressed in multiple cancer types. Clinical studies have shown that increased serum…